CHGA — Change Agents Share News
0.000.00%
Last trade - 00:00Development Research Program
Brief: Avalon Globocare And Adial Pharmaceuticals Announce Strategic Collaboration For Global Distribution Of Covid-19 Test Devices
Brief: Avalon Globocare Says Ava-001 Car T-Cell Therapy Clinical Trial To Include Enrollment Of Patients With Relapsed Refractory Non-Hodgkin Lymphoma
Brief: Avalon Globocare Announces Mesenchymal Stromal Cell Therapeutic Platform For Covid-19 And Acute Graft Versus Host Disease
U.S. STOCKS ON THE MOVE-Hudson, Momenta Pharma, Inhibrx
Avalon GloboCare: Jumps on distribution rights for COVID-19 test kit
Brief: Avalon Globocare Announces Commercialization, Distribution Agreement With Cellex For Covid-19 Antibody Rapid Test Kit
Brief: Avalon Globocare Expands AVA-Trap Program To Treat COVID-19 And CAR-T Related Cytokine Storms
Brief: Avalon Globocare Provides Updates On Its Lead Scientific And Clinical Programs In Car T-Cell Therapy And Covid-19
Brief: Avalon Reports Successful Completion Of Phase I Study Of Car T-Cell Therapy Candidate
Brief: Avalon Globocare Achieves Milestones In Advancing Novel Intranasal And Oral Covid-19 Vaccine Candidate
Brief: Avalon GloboCare Announces Agreement For Development Of Next Generation Cellular Immunotherapy Flash-Car Technology
U.S. STOCKS ON THE MOVE-Boeing, Chesapeake Energy, Ideanomics
develop COVID-19 diagnostic tests
Brief: Avalon Globocare Announces Diagnostic Platform For Point-Of-Care Rapid Detection Of Covid-19 And Its Clinically Relevant Mutation Strains
Avalon GloboCare: Rises as therapy shows promise in combating cytokine storm
Brief: Avalon Globocare Achieves Major Milestones Advancing Immunotherapeutic Program Towards Combatting Cytokine Storm Associated With Covid-19 Lung Damage And Mortality
Brief: Avalon Globocare Files For Common Stock Shelf Of Up To $13 Million
Brief: Avalon Globocare Says Entered Into A Subscription Agreement With WLM Ltd